Correlation Between Sonnet Biotherapeutics and HTG Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and HTG Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and HTG Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and HTG Molecular Diagnostics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and HTG Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of HTG Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and HTG Molecular.

Diversification Opportunities for Sonnet Biotherapeutics and HTG Molecular

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sonnet and HTG is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and HTG Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HTG Molecular Diagnostics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with HTG Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HTG Molecular Diagnostics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and HTG Molecular go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and HTG Molecular

If you would invest  122.00  in Sonnet Biotherapeutics Holdings on June 9, 2025 and sell it today you would earn a total of  163.00  from holding Sonnet Biotherapeutics Holdings or generate 133.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Sonnet Biotherapeutics Holding  vs.  HTG Molecular Diagnostics

 Performance 
       Timeline  
Sonnet Biotherapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
HTG Molecular Diagnostics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, HTG Molecular is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Sonnet Biotherapeutics and HTG Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonnet Biotherapeutics and HTG Molecular

The main advantage of trading using opposite Sonnet Biotherapeutics and HTG Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, HTG Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HTG Molecular will offset losses from the drop in HTG Molecular's long position.
The idea behind Sonnet Biotherapeutics Holdings and HTG Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.